Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 768938, 8 pages
http://dx.doi.org/10.1155/2014/768938
Research Article

The Inhibitory Effect of a Novel Polypeptide Fraction from Arca subcrenata on Cancer-Related Inflammation in Human Cervical Cancer HeLa Cells

1Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou 510632, China
2Department of Pharmacology, Jinan University, Guangzhou 510632, China

Received 31 August 2013; Accepted 20 November 2013; Published 9 February 2014

Academic Editors: E. Hopper-Borge and S. Mocellin

Copyright © 2014 Yu Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. S. S. Kumar, R. A. Nazeer, and R. Jaiganesh, “Purification and identification of antioxidant peptides from the skin protein hydrolysate of two marine fishes, horse mackerel (Magalaspis cordyla) and croaker (Otolithes ruber),” Amino Acids, vol. 42, no. 5, pp. 1641–1649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Wu and Z. X. Zhang, “Scavenging effects of extracts of Scapharca subcrenata on oxygen free radical,” Modern Food Sciences and Technology, vol. 26, no. 3, pp. 238–240, 2010. View at Google Scholar
  3. N. Y. Yoon, H. R. Kim, H. Y. Chung, and J. S. Choi, “Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats,” Archives of Pharmacal Research, vol. 31, no. 12, pp. 1564–1571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-W. Feng, Q. Li, and L.-F. Kong, “Isolation and characterization of 14 polymorphic microsatellite loci in the ark shell Scapharca subcrenata (Bivalvia: Arcidae),” Conservation Genetics, vol. 10, no. 4, pp. 1125–1127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. X. S. Guo and Y. Li, Marine Traditional Chinese Medicines, Sciences Press, Beijing, China, 2003.
  6. X. Q. Hu, H. M. Wu, Z. M. Lin, and X. P. Fan, “Preliminary study on physicochemical property of glycosaminoglycan from Arca subcrenata Lischke and its effects on immune organs of mice,” Modern Food Sciences and Technology, vol. 24, no. 8, pp. 763–766, 2008. View at Google Scholar
  7. L. Wang, Y. M. He, and Q. S. Yao, “Studies on immunomodulation of polysaccharide from Arca subcrenata Lischke,” West China Journal of Pharmaceutical Sciences, vol. 24, no. 4, pp. 340–342, 2009. View at Google Scholar
  8. Y. He, C. Liu, Y. Chen et al., “Isolation and structural characterization of a novel polysaccharide prepared from Arca subcrenata Lischke,” Journal of Bioscience and Bioengineering, vol. 104, no. 2, pp. 111–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Song, T. Li, R. Yu, C. Yan, S. Ren, and Y. Zhao, “Antioxidant activities of hydrolysates of Arca subcrenata prepared with three proteases,” Marine Drugs, vol. 6, no. 4, pp. 607–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. M. J. Schoell, M. F. Janicek, and R. Mirhashemi, “Epidemiology and biology of cervical cancer,” Seminars in Surgery Oncology, vol. 16, no. 3, pp. 203–211, 1999. View at Publisher · View at Google Scholar
  11. X. J. Hu, L. Y. Song, L. J. Huang, Q. Zheng, and R. M. Yu, “Antitumor effect of a polypeptides fraction from Arca subcrenatain vitro and in vivo,” Marine Drugs, vol. 10, no. 12, pp. 2782–2794, 2012. View at Publisher · View at Google Scholar
  12. L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, “Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982. View at Publisher · View at Google Scholar · View at Scopus
  13. D. L. Laskin and K. J. Pendino, “Macrophages and inflammatory mediators in tissue injury,” Annual Review of Pharmacology and Toxicology, vol. 35, no. 10, pp. 655–677, 1995. View at Google Scholar · View at Scopus
  14. R. Korhonen, A. Lahti, H. Kankaanranta, and E. Moilanen, “Nitric oxide production and signaling in inflammation,” Current Drug Targets. Inflammation and Allergy, vol. 4, no. 4, pp. 471–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Costanzo, S. K. Lutgendorf, A. K. Sood, B. Andersen, J. Sorosky, and D. M. Lubaroff, “Psychosocial factors and interleukin-6 among women with advanced ovarian cancer,” Cancer, vol. 104, no. 2, pp. 305–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Lee, Y. T. Kim, S. W. Kim et al., “Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma,” Clinical and Vaccine Immunology, vol. 16, no. 6, pp. 959–961, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-O. Atchaneeyasakul, M. Uiprasertkul, and A. Trinavarat, “Cyclooxygenase-2 expression in retinoblastoma: an immunohistochemical analysis,” Current Eye Research, vol. 35, no. 3, pp. 242–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Hwang, D. Scollard, J. Byrne, and E. Levine, “Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer,” Journal of the National Cancer Institute, vol. 90, no. 6, pp. 455–460, 1998. View at Google Scholar · View at Scopus
  19. K. Holmes, B. Egan, N. Swan, and C. O'Morain, “Genetic mechanisms and aberrant gene expression during the development of gastric intestinal metaplasia and adenocarcinoma,” Current Genomics, vol. 8, no. 6, pp. 379–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Demaria, E. Pikarsky, M. Karin et al., “Cancer and inflammation: promise for biologic therapy,” Journal of Immunotherapy, vol. 33, no. 4, pp. 335–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Faulkner, “Marine natural products,” Natural Product Reports, vol. 19, no. 1, pp. 1–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. H. G. Munro, J. W. Blunt, E. J. Dumdei et al., “The discovery and development of marine compounds with pharmaceutical potential,” Journal of Biotechnology, vol. 70, no. 1–3, pp. 15–25, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. Scheuer, “Marine natural products: diversity in molecular structure and bioactivity,” Advances in Experimental Medicine and Biology, vol. 391, no. 11, pp. 1–8, 1996. View at Google Scholar · View at Scopus
  24. G. K. Zhang, H. Y. Liu, F. S. Qi, and Y. H. Wang, “Changes of ATP content during keeping-alive Scapharca subcrenata,” Food Science and Technology, vol. 36, no. 1, pp. 120–123, 2011. View at Google Scholar
  25. M. Y. Tjiong, N. van der Vange, J. S. ter Schegget, M. P. M. Burger, F. W. J. ten Kate, and T. A. Out, “Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia,” Cytokine, vol. 14, no. 6, pp. 357–360, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Karin and F. R. Greten, “NF-κB: linking inflammation and immunity to cancer development and progression,” Nature Reviews Immunology, vol. 5, no. 10, pp. 749–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. X.-F. Sun and H. Zhang, “NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases,” Histology and Histopathology, vol. 22, no. 12, pp. 1387–1398, 2007. View at Google Scholar · View at Scopus
  28. S. F. Kim, D. A. Huri, and S. H. Snyder, “Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2,” Science, vol. 310, no. 5756, pp. 1966–1970, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Y. Baek, W. Hur, J. S. Wang, S. H. Bae, and S. K. Yoon, “Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest,” World Journal of Gastroenterology, vol. 13, no. 8, pp. 1175–1181, 2007. View at Google Scholar · View at Scopus
  30. D. S. Meng, J. S. Lv, and S. L. Wang, “Cyclooxygenase enzyme and gastroenterol pathophysiology,” Chinese Journal of Pathophysiology, vol. 18, no. 5, pp. 584–587, 2002 (Chinese). View at Google Scholar
  31. R. A. Soslow, A. J. Dannenberg, and D. Rush, “COX-2 is expressed in human pulmonary, colonic, and mammary tumors,” Cancer, vol. 89, no. 12, pp. 2637–2645, 2000. View at Google Scholar
  32. H. J. Kim, H.-G. Wu, I. A. Park, and S. W. Ha, “High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 55, no. 1, pp. 16–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Oshima, J. E. Dinchuk, S. L. Kargman et al., “Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2),” Cell, vol. 87, no. 5, pp. 803–809, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Kawamori, C. V. Rao, K. Seibert, and B. S. Reddy, “Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis,” Cancer Research, vol. 58, no. 3, pp. 409–412, 1998. View at Google Scholar · View at Scopus
  35. S. M. Fischer, H. H. Lo, G. B. Gordon, K. Seibert, G. Kelloff, and R. A. Lubet, “Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet-light induced skin carcinogenesis,” Molecular Carcinogenesis, vol. 25, no. 4, pp. 231–240, 1999. View at Publisher · View at Google Scholar
  36. M. Stolina, S. Sharma, Y. Lin et al., “Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis,” Journal of Immunology, vol. 164, no. 1, pp. 361–370, 2000. View at Google Scholar · View at Scopus
  37. E. Okajima, A. Denda, S. Ozono et al., “Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl) nitrosamine,” Cancer Research, vol. 58, no. 14, pp. 3028–3031, 1998. View at Google Scholar · View at Scopus
  38. X. H. Liu, A. Kirschenbaum, S. Yao, R. Lee, J. F. Holland, and A. C. Levine, “Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo,” The Journal of Urology, vol. 164, no. 3, pp. 820–825, 2000. View at Google Scholar · View at Scopus